Health impact and toxicological effects of nanomaterials in the lung

Respirology

Volumn 17, Issue 5, 2012, Pages 743-758

  Kendall, Michaela ^a   Holgate, Stephen ^b  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

engineered nanoparticle (ENP); exposure; mechanisms of toxicity; nanoparticle (NP); toxicology

Indexed keywords

ANTINEOPLASTIC AGENT; GOLD NANOPARTICLE; LIGAND; MACROGOL; NANOMATERIAL; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TITANIUM DIOXIDE; WATER;

ADAPTIVE IMMUNITY; ADSORPTION; AEROSOL; ASTHMA; ATMOSPHERE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL INTERACTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLEARANCE; COLLOID; COMBUSTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG TARGETING; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INNATE IMMUNITY; LUNG TOXICITY; NANOBIOTECHNOLOGY; NANOENGINEERING; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PARTICLE SIZE; PARTICULATE MATTER; PHYSICAL CHEMISTRY; PNEUMONIA; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK FACTOR; SURFACE PROPERTY;

CELL COMMUNICATION; HEALTH STATUS; HUMANS; LUNG; MODELS, BIOLOGICAL; NANOPARTICLES; NANOSTRUCTURES;

EID: 84862979827     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02171.x     Document Type: Review

References (194)

1. EC. 2011. Official Journal of the European Union (20.10.2011) Recommendations. Commission Recommendation of 18 October 2011 on the definition of nanomaterial. [Accessed 23 Nov 2011.] Available from URL
2. Woodrow Wilson Center for International Center for Scholars. 2011. Project on Emerging Nanotechnologies: Nanotechnology Consumer Products Inventory. [Accessed 23 Nov 2011.] Available from URL
3. NIOSH. 2010. Occupational Exposure to Carbon Nanotubes and Nanofibres. Current Intelligence Bulletin, National Institute for Occupational Safety and Health. Washington, USA. November 2010 Draft. [Accessed 23 Nov 2011.] Available from URL
4. Tomi NS, Kränke B, Aberer PW,. A silver man. Lancet 2004; 363: 532-3.
5. NIOSH. 2011. Occupational exposure to titanium dioxide. Current Intelligence Bulletin 63, National Institute for Occupational Safety and Health. Washington, USA. [Accessed 23 Nov 2011.] Available from URL
6. Krug HF, Wick P,. Nanotoxicology: an interdisciplinary challenge. ACIE 2011; 50: 1260-78.
7. Card JW, Zeldin DC, Bonner JC, et al,. Pulmonary applications and toxicity of engineered nanoparticles. Am. J. Physiol. (Lung) 2008; 295: L400-11.
8. Nel AE, Madler L, Velegol D, et al,. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009; 8: 543-57.
9. Royal Commission on Environmental Pollution. 2008. Novel materials in the environment: the case of nanotechnology. 27th Report.
10. Kagan VE, Bayir H, Shvedova AA,. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine 2005; 1: 313-16. (Pubitemid 43963640)
11. Nel A, Xia T, Madler L, et al,. Toxic potential of materials at the nanolevel. Science 2006; 311: 622-7. (Pubitemid 43191298)
12. Bonner JC,. Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc. Am. Thorac. Soc. 2010; 7: 138-41.
13. Inoue K-I, Takano H,. Facilitating effects of nanoparticles/materials on sensitive immune-related lung disorders. J. Nanomater. 2011. doi:10.1155/2011/407402.
14. Maynard AD,. Don't define nanomaterials. Nature 2011; 475: 31.
15. House of Lords Science and Technology Committee. 2010. Nanotechnologies and food. House of Lords Science and Technology Committee Report, HMSO, London. January 7th 2010.
16. Song Y, Li X, Du X,. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur. Respir. J. 2009; 34: 559-67.
17. Wu M, Gordon RE, Herbert R, et al,. Case report: lung disease in World Trade Center responders exposed to dust and smoke: carbon nanotubes found in the lungs of World Trade Center patients and dust samples. Environ. Health Perspect. 2010; 118: 499-504.
18. Brunekreef B, Holgate ST,. Air pollution and health. Lancet 1996; 360: 1233-42.
19. Oberdorster G, Oberdorster E, Oberdorster J,. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005; 113: 823-39. (Pubitemid 40984181)
20. Pope CA,. Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk? Environ. Health Perspect. 2000; 108: 713-23.
21. COMEAP Report. 2010. The mortality effects of long term exposure to particulate air pollution in the United Kingdom. UK Department of Health.
22. Pope CA, Burnett RT, Turner MC, et al,. Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships. Environ. Health Perspect. 2011; 119: 1616-21.
23. Asgharian B, Price OT,. Deposition of ultrafine (nano) particles in the human lung. Inhal. Toxicol. 2007; 19: 1045-54. (Pubitemid 350034850)
24. Gehr P, Blank F, Rothen-Rutishauser BM,. Fate of inhaled particles after interaction with the lung surface. Paediatr. Respir. Rev. 2006; 7: S73-5. (Pubitemid 43906244)
25. Alexis NE, Lay JC, Zeman KL, et al,. In vivo particle uptake by airway macrophages in healthy volunteers. Am. J. Respir. Cell Mol. Biol. 2005; 34: 305-13.
26. Holgate ST,. Exposure, uptake, distribution and toxicity of nanomaterials in humans. J. Biomed. Nanotech. 2010; 6: 1-19.
27. Renwick LC, Donaldson K, Clouter A,. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol. Appl. Pharmacol. 2001; 172: 119-27. (Pubitemid 32373134)
28. Kulkarni N, Pierse N, Rushton L, et al,. Carbon in airway macrophages and lung function in children. N. Engl. J. Med. 2006; 355: 21-30.
29. Liu J, Wong HL, Moselhy J, et al,. Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer 2006; 51: 377-86. (Pubitemid 43265822)
30. Shimada A, Kawamura N, Okajima M, et al,. Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse. Toxicol. Pathol. 2006; 34: 949-57. (Pubitemid 46011147)
31. Mühlfeld C, Geiser M, Kapp N, et al,. Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the 'relative deposition index': evidence for clearance through microvasculature. Part. Fibre Toxicol. 2007; 4: 7-14.
32. 10: iron-mediated generation of hydroxyl radicals. Environ. Health Perspect. 1997; 105: 1285-9.
33. 2.5 in favour of particle aggregation: a protective mechanism. Am. J. Physiol. (Lung) 2002; 282: L109-14. (Pubitemid 34654187)
34. Rothen-Rutishauser B, Mühlfeld C, Blank F, et al,. Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part. Fibre Toxicol. 2007; 4: 9-18.
35. Lippmann M, Chen LC,. Health effects of concentrated ambient air particulate matter (CAPs) and its components. Crit. Rev. Toxicol. 2009; 39: 865-913.
36. Kato T, Yashiro T, Murata Y, et al,. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tissue Res. 2003; 311: 47-51. (Pubitemid 35478223)
37. Kreyling WG, Moller W, Schmid O, et al,. Chapter 7 Translocation of inhaled nanoparticles. In:, Casee FR, Mills NL, Newby DE, (eds) Cardiovascular Effects of Inhaled Ultrafine and Nano-Sized Particles. John Wiley and Sons, New Jersey, 2011; 125-43.
38. Geiser M, Kreyling W,. Deposition and biokinetics of inhaled nanoparticles. Part. Fibre Toxicol. 2010; 20 (7): 2-18.
39. Blank F, Rothen-Rutishauser B, Gehr P,. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am. J. Respir. Cell Mol. Biol. 2007; 36: 669-77. (Pubitemid 46871421)
40. Zeka A, Sullivan JR, Vokonas PS, et al,. Inflammatory markers and particulate air pollution: characterizing the pathway to disease. Int. J. Epidemiol. 2006; 35: 1347-54. (Pubitemid 44605564)
41. Kendall M, Brown L, Trought K,. Molecular adsorption at particle surfaces: a PM toxicity mediation mechanism. Inhal. Toxicol. 2004; 16: 99-105. (Pubitemid 38923906)
42. 2.5) sequester lung surfactant and amino acids from human lung lavage. Am. J. Physiol. (Lung) 2007; 293: L1053-8. (Pubitemid 47572254)
43. McCormack FX, Whitsett JA,. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J. Clin. Invest. 2002; 109: 707-12. (Pubitemid 34263144)
44. Clark HW, Reid KB, Sim RB,. Collectins and innate immunity in the lung. Microbes Infect. 2000; 2: 273-8. (Pubitemid 30167660)
45. Mason RJ, Greene K, Voelker DR,. Surfactant protein A and surfactant protein D in health and disease. Am. J. Physiol. (Lung) 1998; 19: L1-13.
46. Brown DM, Wilson MR, MacNee W, et al,. Size-dependent pro-inflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 2001; 175: 191-9. (Pubitemid 32917742)
47. Kendall M, Hutton BM, Tetley TD, et al,. Investigation of fine atmospheric particle surfaces and lung lining fluid interactions using XPS. Appl. Surf. Sci. 2001; 178 (1-4): 27-36. (Pubitemid 32543590)
48. Hirama N, Shibata Y, Otake K, et al,. Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema. Respirology 2007; 12: 191-201. (Pubitemid 46239391)
49. Salvador-Morales C, Townsend P, Flahaut E, et al,. Binding of pulmonary SPs to carbon nanotubes; potential for damage to lung immune defence. Carbon 2007; 45: 607-17. (Pubitemid 46148826)
50. Shvedova AA, Fabisiak JP, Kisin ER, et al,. Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity. Am. J. Respir. Cell Mol. Biol. 2008; 38: 579-90. (Pubitemid 351758677)
51. Tuvim MJ, Evans SE, Clement CG, et al,. Augmented lung inflammation protects against Influenza A Pneumonia. PLoS ONE 2009; 4: e4176.
52. 2.5 surface chemistry and interactions with broncho-alveolar lavage fluid (BALF). Inhal. Toxicol. 2004; 16: 115-29. (Pubitemid 38923908)
53. Peters A, Doring A, Wichmann HE, et al,. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 1997; 349: 1582-7. (Pubitemid 27229137)
54. Araujo J, Nel A,. Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress. Part. Fibre Toxicol. 2009; 6: 24-42.
55. Peters A, Veronesi B, Calderõn-Garcidueñas L, et al,. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part. Fibre Toxicol. 2006; 3: 13-25.
56. Lippmann M, Hwang JS, Maciejczyk P, et al,. PM source apportionment for short-term cardiac function changes in ApoE-/-mice. Environ. Health Perspect. 2005; 113: 1575-9. (Pubitemid 41614914)
57. Ferin J, Oberdorster G, Penney DP,. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 1992; 6: 535-42.
58. Smith KR, Peel JL,. Mind the Gap. Environ. Health Perspect. 2010; 118: 1643-5.
59. Kreyling WG, Semmler M, Erbe F, et al,. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health A 2002; 65: 1513-30. (Pubitemid 35217498)
60. Semmler-Behnke M, Kreyling WG, Lipka J, et al,. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008; 4: 2108-11.
61. Xia T, Kovochich M, Liong M, et al,. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 2009; 3: 3273-86.
62. Rejman J, Oberle V, Zuhorn IS, et al,. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 2004; 377: 159-69. (Pubitemid 38114443)
63. Kemp SJ, Thorley AJ, Gorelik J, et al,. Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. Am. J. Respir. Cell Mol. Biol. 2008; 39: 591-7.
64. Maynard AD,. Assessing exposure to airborne nanomaterials: current abilities and future requirements. Nanotoxicology 2007; 1: 26-41. (Pubitemid 46570248)
65. Feitsans IL,. Forecasting nano law risk management protecting public health under international law. Doctoral thesis, August 1 2011.
66. Kendall K, Kendall M, Rehfeldt F,. Adhesion of Cells, Viruses and Nanoparticles. Springer, Heidelberg, 2011.
67. Kendall M, Ding P, Kendall K,. Submicron and nanoparticle interactions with fibrinogen: the importance of aggregation state. Nanotoxicology 2011; 5: 55-65.
68. Wright JR,. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 2005; 5: 58-68. (Pubitemid 40070331)
69. Savic R, Luo L, Eisenberg A, et al,. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003; 300: 615-18. (Pubitemid 36520581)
70. Al-Jamal WT, Kostarelos K,. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Nanomedicine 2007; 2: 85-98. (Pubitemid 46845780)
71. Mahmud A, Discher DE,. Lung vascular targeting through inhalation delivery: insight from filamentous viruses and other shapes. IUBMB Life 2011; 63: 607-12.
72. Niidome T, Yamagata M, Okamoto Y, et al,. PEG-modified gold nanorods with a stealth character for in vivo application. J. Control. Release 2006; 114: 243-347.
73. Wick P, Manser P, Limbach LK, et al,. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol. Lett. 2007; 168: 121-31. (Pubitemid 46054362)
74. Muller J, Huaux F, Moreau N, et al,. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 2005; 207: 221-31. (Pubitemid 41207915)
75. Pauluhn J,. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol. Sci. 2010; 113: 226-42.
76. Porter DW, Hubbs AF, Mercer RR, et al,. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010; 269: 136-47.
77. Poland CA, Duffin R, Kinloch I, et al,. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 2008; 3: 423-8.
78. Ryman-Rasmussen JP, Cesta MF, Brody AR, et al,. Inhaled multi-walled carbon nanotubes reach the sub- pleural tissue in mice. Nat. Nanotechnol. 2009; 4: 747-51.
79. Lindberg HK, Falck GCM, Suhonen S, et al,. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicol. Lett. 2009; 186: 166-73.
80. Halappanavar S, Jackson P, Williams A, et al,. Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study. Environ. Mol. Mutagen. 2011; 52: 425-39.
81. Geiser M, Schürch S, Gehr P,. Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. J. Appl. Physiol. 2003; 94: 1793-801. (Pubitemid 36457427)
82. Oyelere AK, Chen PC, Huang X, et al,. Peptide-conjugated gold nanorods for nuclear targeting. Bioconjug. Chem. 2007; 18: 1490-7. (Pubitemid 47464056)
83. Reddy ST, Swartz MA, Hubbell JA,. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 2006; 27: 573-9. (Pubitemid 44708833)
84. Rozhkova EA, Ulasov I, Lai B, et al,. A high-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett. 2009; 9: 3337-42.
85. Ahamed M, Karns M, Goodson M, et al,. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol. Appl. Pharmacol. 2008; 233: 404-10.
86. Oberdorster G, Ferin J, Lehnert BE,. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 1994; 102: 173-9. (Pubitemid 24364846)
87. Liu Y, Miyoshi H, Nakamura M,. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer 2007; 120: 2527-37. (Pubitemid 46651272)
88. Linse S, Cabaleiro-Lago C, Xue W-F, et al,. Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. USA 2007; 104: 8691-869.
89. Sivak O, Darlington J, Gershkovich P, et al,. Protonated nanostructured aluminosilicate (NSAS) reduces plasma cholesterol concentrations and atherosclerotic lesions in Apolipoprotein E deficient mice fed a high cholesterol and high fat diet. Lipids Health Dis. 2009; 8: 30-4.
90. Warheit DB, Reed KL, Sayes CM,. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Inhal. Toxicol. 2009; 21: 61-7.
91. Colvin VL,. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 2003; 21: 1166-70. (Pubitemid 37203347)
92. Lundqvist M, Stigler J, Elia G, et al,. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 2008; 105: 14265-70.
93. Cabaleiro-Lago C, Lynch I, Dawson KA, et al,. Inhibition of IAPP and IAPP(20-29) fibrillation by polymeric nanoparticles. Langmuir 2010; 26: 3453-61.
94. Seagrave JC, Knall C, Mcdonald JD, et al,. Diesel particulate material binds and concentrates a proinflammatory cytokine that causes neutrophil. Inhal. Toxicol. 2004; 16: 93-8. (Pubitemid 38923905)
95. Doak SH, Griffiths SM, Manshian B, et al,. Confounding experimental considerations in nanogenotoxicology. Mutagenesis 2009; 24: 285-93.
96. Hillaireau H, Couvreur P,. Nanocarriers' entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 2009; 66: 2873-96.
97. Stearns RC, Paulauskis JD, Godleski JJ,. Endocytosis of ultrafine particles by A549 cells. Am. J. Respir. Cell Mol. Biol. 2001; 24: 108-15. (Pubitemid 32152071)
98. Huang M, Wu W, Qian J, et al,. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles. Acta Pharmacol. Sin. 2005; 26: 1512-18. (Pubitemid 41789542)
99. Duffin R, Tran L, Brown D, et al,. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol. 2007; 19: 849-56. (Pubitemid 47237750)
100. Bermudez E, Mangum JB, Wong BA, et al,. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol. Sci. 2004; 77: 347-57. (Pubitemid 38262608)
101. Vroman L, Adams AL, Fischer GC, et al,. Interaction of high molecular-weight kininogen, factor-Xii, and fibrinogen in plasma at interfaces. Blood 1980; 55: 156-9. (Pubitemid 10211912)
102. Florence AT, Hillery AM, Hussain N, et al,. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J. Control. Release 1995; 36 (1-2): 39-46.
103. Lynch I, Dawson KA,. 2008. Protein-nanoparticle interactions. NanoToday 2008; 3: 40-7.
104. Monopoli MP, Walczyk D, Campbell A, et al,. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011; 133: 2525-34.
105. Lundqvist M, Stigler J, Cedervall T, et al,. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011; 5: 7503-9.
106. Lockman PR, Koziara JM, Mumper RJ, et al,. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J. Drug Target. 2004; 12: 635-41. (Pubitemid 40100711)
107. John TA, Vogel SM, Minshall RD, et al,. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002; 284: L187-96.
108. Johnson CJ, Zhukovsky N, Cass AE, et al,. Proteomics, nanotechnology and molecular diagnostics. Proteomics 2008; 8: 715-30. (Pubitemid 351362932)
109. Dutta D, Sundaram SK, Teeguarden JG, et al,. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 2007; 100: 303-15. (Pubitemid 47617826)
110. Barlow PG, Clouter-Baker A, Donaldson K, et al,. Carbon black nanoparticles induce Type II apithelial cells to release chemotaxinx for alveolar macrophages. Part. Fibre Toxicol. 2005; 2: 11-24.
111. Bermudez E, Mangum JB, Asgharian B, et al,. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol. Sci. 2002; 70: 86-97. (Pubitemid 35331794)
112. Mahmoudi M, Lynch I, Ejtehadi MR, et al,. Protein-nanoparticle interactions: opportunities and challenges. Chem. Rev. 2011; 111: 5610-37.
113. Lesniak A, Campbell A, Monopoli MP, et al,. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 2010; 31: 9511-18.
114. Schulze C, Schaefer UF, Ruge CA, et al,. Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur. J. Pharm. Biopharm. 2011; 77: 376-3.
115. Sayes CM, Reed KL, Warheit DB,. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 2007; 97: 163-80. (Pubitemid 47072165)
116. Pulskamp K, Diabaté S, Krug HF,. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol. Lett. 2007; 168: 58-74. (Pubitemid 44909723)
117. Muller L, Riediker M, Wick P, et al,. Oxidative stress and inflammation response after nanoparticle exposure: differences between human lung cell monocultures and an advanced three-dimensional model of the human epithelial airways. J. R. Soc. Interface 2010; 7: S27-40.
118. Kreyling W, Semmler M, Erbe F, et al,. Minute translocation of inhlaed ultrafine insoluble iridium particles from lung epithelium to extrapulmonary tissues. Ann. Occup. Hyg. 2002; 46: 223-6.
119. Guntur VP, Dhand R,. Inhaled insulin: extending the horizons of inhalation therapy. Respir. Care 2007; 52: 911-22.
120. Geiser M, Casaulta M, Kupferschmid B, et al,. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am. J. Respir. Cell Mol. Biol. 2008; 38: 371-6. (Pubitemid 351567707)
121. Mo Y, Barnett ME, Takemoto D, et al,. Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene. Mol. Vis. 2007; 13: 746-57. (Pubitemid 46830326)
122. AshaRani PV, Mun GLK, Hande MP, et al,. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009; 3: 279-90.
123. Wang XB, Gao HY, Hou BL, et al,. Nanoparticle realgar powders induce apoptosis in U937 cells through caspase MAPK and mitochondrial pathways. Arch. Pharm. Res. 2007; 30: 653-8.
124. Xu X, Liu C, Xu Z, et al,. Long-term exposure to ambient fine particulate pollution induces insulin resistance and mitochondrial alteration in adipose tissue. Toxicol. Sci. 2011; 124: 88-98.
125. Jacobsen NR, Moller P, Jensen KA, et al,. Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice. Part. Fibre Toxicol. 2009; 6: 2-16.
126. Fabian E, Landsiedel R, Ma-Hock L, et al,. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 2008; 82: 151-7.
127. Oberdorster G, Sharp Z, Atudorei V, et al,. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 2004; 16: 437-45. (Pubitemid 38685135)
128. Sadauskas E, Wallin H, Stoltenberg M, et al,. Kupffer cells are central in the removal of nanoparticles from the organism. Part. Fibre Toxicol. 2007; 4: 10-16.
129. Goto Y, Hogg JC, Shih CH, et al,. Exposure to ambient particles accelerates monocyte release from bone marrow in atherosclerotic rabbits. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 287: L79-85. (Pubitemid 38787653)
130. Goto Y, Ishii H, Hogg JC, et al,. Particulate matter air pollution stimulates monocyte release from the bone marrow. Am. J. Respir. Crit. Care Med. 2004; 170: 891-7. (Pubitemid 39346485)
131. Chen J, Tan M, Nemmar A, et al,. Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. Toxicology 2006; 222: 195-201.
132. Choi HS, Ashitate Y, Lee JH, et al,. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 2010; 28: 1300-3.
133. Elder A, Gelein R, Silva V, et al,. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 2006; 114: 1172-8. (Pubitemid 44184673)
134. Seaton A, Macnee W, Donaldson K, et al,. Particulate air pollution and acute health effects. Lancet 1995; 345: 176-8.
135. Brook RD, Rajagopalan S, Pope CA, et al,. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010; 121: 2331-78.
136. Metzger KB, Klein M, Flanders WD, et al,. Ambient air pollution and cardiac arrhythmias in patients with implantable defibrillators. Epidemiology 2007; 18: 585-92. (Pubitemid 47263033)
137. Ruckerl R, Phipps RP, Schneider A, et al,. Ultrafine particles and platelet activation in patients with coronary heart disease-results from a prospective panel study. Part. Fibre Toxicol. 2007; 4: 1-14.
138. Jun EA, Lim KM, Kim K, et al,. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology 2011; 5: 157-67.
139. Radomski A, Jurasz P, Alonso-Escolano D, et al,. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 2005; 146: 882-93. (Pubitemid 41622255)
140. Tavano R, Segat D, Reddi E, et al,. Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine 2010; 5: 881-96.
141. Xia T, Kovochich M, Liong M, et al,. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008; 2: 2121-34.
142. Karlsson HL, Cronholm P, Gustafsson J, et al,. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008; 21: 1726-32.
143. Valko M, Izakovic M, Mazur M, et al,. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 2004; 266: 37-56. (Pubitemid 39562306)
144. 2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol. Lett. 2009; 187: 77-83.
145. Gharbi N, Pressac M, Hadchouel M, et al,. C[60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005; 5: 2578-85. (Pubitemid 43088916)
146. Fröhlich E, Samberger C, Kueznik T, et al,. Cytotoxicity of nanoparticles independent from oxidative stress. J. Toxicol. Sci. 2009; 34: 363-75.
147. Deng ZJ, Liang M, Monteiro M, et al,. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 2011; 6: 39-44.
148. Zolnik BS, Gonzalez-Fernandez A, Sadrieh N, et al,. Minireview: nanoparticles and the immune system. Endocrinology 2010; 151: 458-65.
149. Hamad I, Al-Hanbali O, Hunter AC, et al,. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. ACS Nano 2010; 4: 6629-38.
150. Dobrovolskaia MA, McNeil SE,. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007; 2: 469-78. (Pubitemid 47220069)
151. Hougaard KS, Jackson P, Jensen KA, et al,. Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-Titan). A study in mice. Part. Fibre Toxicol. 2010; 7: 16-31.
152. Jackson P, Hougaard KS, Boisen AMZ, et al,. Pulmonary exposure to carbon black by inhalation or instillation in pregnant mice: effects on liver DNA strand breaks in dams and offspring. Nanotoxicology 2011. doi: 10.3109/17435390.2011.587902.
153. Clement CG, Evans SE, Evans CM, et al,. Stimulation of lung innate immunity protects against lethal Pneumococcal Pneumonia in mice. Am. J. Respir. Crit. Care Med. 2008; 177: 1322-30. (Pubitemid 351860909)
154. Zhang L, Wang M, Kang X, et al,. Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J. Proteome Res. 2009; 9: 1631-8.
155. Clark HW, Palaniyar N, Hawgood S, et al,. A recombinant fragment of human surfactant protein D reduces alveolar macrophage apoptosis and pro-inflammatory cytokines in mice developing pulmonary emphysema. Ann. N. Y. Acad. Sci. 2003; 1010: 113-16. (Pubitemid 38264960)
156. Deb R, Shakib F, Reid KBM, et al,. Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D. J. Biol. Chem. 2007; 282: 36808-19.
157. Gaiha GD, Dong T, Palaniyar N, et al,. Surfactant protein A binds to HIV and inhibits direct infection of CD4+ cells, but enhances dendritic cell-mediated viral transfer. J. Immunol. 2008; 181: 601-9.
158. Kendall M, Ding P, Mackay R, et al,. Surfactant protein D alters cellular uptake of particles and nanoparticles. Nanotoxicology 2011. doi:10.3109/17435390.2012.689880
159. Hussain S, Vanoirbeek JAJ, Luyts K, et al,. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur. Respir. J. 2011; 37: 299-309.
160. Mühlfeld C, Rothen-Rutishauser B, Blank F, et al,. Interactions of nanoparticles with pulmonary structures and cellular responses. Am. J. Physiol. (Lung) 2008; 294: L817-29.
161. Blander JM, Medzhitov R,. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440: 808-12.
162. Pele L, Powell JJ,. Microparticles: a link between modern life and inflammatory bowel disease. In:, Colombel JF, Gasche C, Scholmerich J, et al. (eds) Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice, Vol. 140. Springer, Dordrecht, 2005; 123-37.
163. Powell JJ, Thoree V, Pele LC,. Dietary microparticles and their impact on tolerance and immune responsiveness of the gastrointestinal tract. Br. J. Nutr. 2007; 98 (Suppl. 1): S59-63. (Pubitemid 47543479)
164. Xiao C, Puddicombe SM, Field S, et al,. Defective epithelial barrier function in asthma. J. Allergy Clin. Immunol. 2011; 128: 549-56.
165. Hansson GK, Hermansson A,. The immune system in atherosclerosis. Nat. Immunol. 2011; 12: 204-12.
166. O'Neil LA, Bryant CE, Doyle SL,. Therapeutic targeting of Toll- like receptors for infectious and inflammatory diseases and cancer. Pharmacol. Rev. 2009; 61: 177-97.
167. Sitzmann B, Kendall M, Watt J, et al,. Characterisation of airborne particles in London by computer controlled scanning electron microscopy (SEM). Sci. Total Environ. 1999; 241 (1-3): 63-73.
168. Wigzell E, Kendall M, Nieuwenhuijsen M,. 'The spatial and temporal variability of particulates in the home'. J. Expo. Anal. Environ. Epidemiol. 2000; 10: 307-14. (Pubitemid 30463351)
169. Kreyling WG, Hirn S, Schleh C,. Nanoparticles in the lung. Nat. Biotechnol. 2010; 28: 1275-6.
170. Kaegi R,. Nanoparticles in drinking water. EAWAG News 2009; 66: 7-9.
171. Som C, Wick P, Krug H, et al,. Environmental and health effects of nanomaterials in nanotextiles and facade coatings. Environ. Int. 2011; 37: 1131-42.
172. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, et al,. Nano-silver a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009; 3: 109-38.
173. Gottschalk F, Sonderer T, Scholz RW, et al,. Modeled environmental concentrations of engineered nanomaterials (TiO2, ZnO, Ag, CNT, fullerenes) for different regions. Environ. Sci. Technol. 2009; 43: 9216-22.
174. Mueller NC, Nowack B,. Exposure modeling of engineered nanoparticles in the environment. Environ. Sci. Technol. 2008; 42: 4447-53. (Pubitemid 351842389)
175. Larese FF, D'Agostin F, Crosera M, et al,. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 2009; 255: 33-7.
176. Vlachou E, Chipp E, Shale E, et al,. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns 2007; 33: 979-85. (Pubitemid 350051200)
177. Tallury P, Malhotra A, Byrne LM, et al,. 2010. Nanobioimaging and sensing of infectious diseases. Adv. Drug Deliv. Rev. 2010; 62: 424-37.
178. Cho WS, Cho M, Jeong J, et al,. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 2009; 236: 16-24.
179. Kang B, Mackey MA, El-Sayed MA,. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J. Am. Chem. Soc. 2010; 132: 1517-19.
180. Adachi K, Yamada N, Yamamoto K, et al,. In vivo effect of industrial titanium dioxide nanoparticles experimentally exposed to hairless rat skin. Nanotoxicology 2010; 4: 296-306.
181. Harada Y, Ogawa K, Irie Y, et al,. Ultrasound activation of TiO(2) in melanoma tumors. J. Control. Release 2011; 149: 190-5.
182. Johnston HJ, Semmler-Behnke M, Brown DM, et al,. Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. Toxicol. Appl. Pharmacol. 2010; 242: 66-78.
183. Wang L, Zhao W, Tan W,. Bioconjugated silica nanoparticles: development and applications. Nano Res. 2008; 1: 99-115.
184. Huber DL,. Synthesis, properties, and applications of iron nanoparticles. Small 2005; 1: 482-501. (Pubitemid 43951747)
185. Apopa PL, Qian Y, Shao R, et al,. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part. Fibre Toxicol. 2009; 6: 1-14.
186. Curtis J, Greenberg M, Kester J, et al,. Nanotechnology and nanotoxicology: a primer for clinicians. Toxicol. Rev. 2006; 25: 245-60.
187. Lanza G, Winter P, Cyrus T, et al,. Nanomedicine opportunities in cardiology. Ann. N. Y. Acad. Sci. 2006; 1080: 451-65. (Pubitemid 44955439)
188. Hannig M, Hannig C,. Nanomaterials in preventive dentistry. Nat. Nanotechnol. 2010; 5: 565-9.
189. Wick P, Malek A, Manser P, et al,. Barrier capacity of human placenta for nanosized materials. Environ. Health Perspect. 2010; 118: 432-6.
190. Takeda K, Suzuki K-I, Ishihara A, et al,. Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems. J. Health Sci. 2009; 55: 95-102.
191. Fedulov AV, Leme A, Yang Z, et al,. Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility. Am. J. Respir. Cell Mol. Biol. 2008; 38: 57-67.
192. Bernstein DM, Hoskins JA,. The health effects of chrysotile: current perspective based upon recent data. Regul. Toxicol. Pharmacol. 2006; 45: 252-64. (Pubitemid 44066626)
193. Schneider T, Brouwer DH, Koponen IK, et al,. Conceptual model for assessment of inhalation exposure to manufactured nanoparticles. J. Expo. Sci. Environ. Epidemiol. 2011; 21: 450-63.
194. Tsai S, Ada E, Isaacs JA, et al,. Airborne nanoparticle exposures associated with the manual handling of nanoalumina and nanosilver in fume hoods. J. Nanopart. Res. 2009; 11: 147-61.